drugset / Trial / NCT04755985

A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132

NCT04755985 ↗

Phase 1 Completed 40 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A study to compare safety, pharmacokinetics and pharmacodynamics of AD-213-B to AD-2132 in healthy volunteers.

Timeline

Start
2021-03-21
Primary completion
2021-05-13
Completion
2021-07-23

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-213-B Unknown — Oral
Subject AD-2132 Unknown — Oral